Statistical analysis 210
Correlations between the total number of HLA-associated substitutions in each 211 individual and clinical parameters (pVL and CD4 count) were performed using Spearman's 212 correlation. To count the total number of HLA-associated substitutions within a given 213
HIV-1 sequence, we first identified all HIV-1 sites within that sequence identified as being 214 associated with any HLA allele. The specific residue at each site was counted as 215 "HLA-associated" if it matched any HLA-associated adapted form, or any residue other 216 than a nonadapted form identified at that position. The HLA alleles expressed by the 217 individual were not considered (unless specifically stated) -rather, our goal was to 218 enumerate the number of HLA-AP associated with any HLA allele in each viral sequence. 219
In analyses where host HLA alleles were not considered, HIV sites harboring residues that 220 simultaneously represented a nonadapted and Adapted form associated with different HLA 221 alleles were excluded from consideration. 222
223
Detection of differential escape between closely-related HLA alleles, and between 224
cohorts. 225
Two types of differential escape were investigated. First, we investigated differential 226 escape between closely-related HLA class I alleles, defined here as (four-digit) HLA 227 subtype members belonging to the same (two-digit) allele group, in the Japanese cohort. 228
Specifically, seven HLA allele groups (A*02, A*26, B*15, B*40, C*03, C*08, and C*14) 229 for which a minimum of two subtype members were represented in the Japanese cohort, 230 were investigated. For example, the HLA-A*02 allele group featured subtypes A*02:01, 231 A*02:06 and A*02:07, while the A*26 allele group featured subtypes A*26:01 and 232 A*26:03. For each allele group, we took the union of all HLA-AP identified for all subtype 233 members of the group. Then, in a pairwise manner, we compared their strengths of 234 selection between all HLA subtype members using a previously-described 235 on October 28, 2017 by guest http://jvi.asm.org/ Downloaded from 11 phylogenetically-corrected interaction test (17) . In this analysis, thresholds of p < 0.05, q < 236 0.2 were used to define significance. 237
Second, we investigated differential HLA-driven escape pathways between Japanese and 238 IHAC cohorts. As outlined in the introduction, HLA-AP identified in human populations 239 will differ to some extent due to the presence (or enrichment) of certain HLA alleles in one 240 population versus another. However in this analysis we were specifically interested in 241 identifying cases where the same HLA allele drove significantly different escape pathways 242 in the two cohorts. To do this, we took the union of all HLA-AP identified in Japan and 243 IHAC cohorts, that were restricted by HLA subtypes observed a minimum of 10 times in 244 both cohorts. We then compared the strength of selection of each HLA-AP in a pairwise 245 manner, between cohorts. The statistical methods used investigate differential escape 246 between Japanese vs. IHAC cohorts are similar to those used to investigate differential 247 escape between HLA subtype members (17), with some modifications as follows. Briefly, a 248 phylogenetically-corrected logistic regression model is constructed using a single HLA 249 allele as a predictor. Using a likelihood ratio test, we then compare this model to a more 250 expressive one that includes an additional interaction term that is 1 if the individual 251 expresses the HLA allele and is in the IHAC cohort, or 0 otherwise. In this way, we can 252 obtain a p-value testing the hypothesis that selection is the same in both cohorts (null 253 hypothesis) or whether selection differs across cohorts (alternative hypothesis). In contrast 254 to the HLA-AP analyses described thus far, the present one does not feature corrections for 255 HLA linkage disequilibrium or HIV codon covariation -and therefore will yield odds ratios 256 of association and p-values that differ slightly from the original cohort-specific values. In 257 the inter-cohort differential escape analysis, significance was defined as p < 0.01, q < 0.05. 
B-infected Japanese individuals. 262
The first objective of our study was to identify and characterize HLA-AP in Japan, a 263 unique population in terms of its HLA class I distribution and predominantly HIV clade B 264 epidemic. Towards this end, we analyzed linked HIV/HLA genotypes from 430 265 antiretroviral therapy-naive Japanese individuals chronically infected with HIV-1 clade B. 266
A total of 78 unique HLA class I alleles, defined at subtype-level (4-digit) resolution, were 267 observed in our cohort (Fig. S1 ) at frequencies consistent with the published literature (23). 268
Of these, 37 (including 9 HLA-A, 17 HLA-B, and 11 HLA-C alleles) were observed in at 269 least 10 individuals, and thus were included in the statistical analysis of HLA-APs (see 270 methods). Amplification and sequencing of HIV-1 Gag, Pol without the transframe (TF) 271 protein, and Nef was successful for 397 (92.3%), 363 (84.4%), and 306 (71.2%) individuals, 272 respectively. As described in the methods, HLA-APs within these three genes were 273 identified using a phylogenetically corrected logistic regression model which corrects for 274 the confounding effects of viral phylogeny, HIV-1 codon covariation and linkage 275 disequilibrium between host HLA class I alleles (16, 17, 20) . A false discovery rate 276 (q-value) approach was employed to address multiple tests. 277
At a threshold of q < 0.2, a total of 284 HLA-APs, comprising 143 adapted and 141 278 non-adapted associations, were identified in Gag (N=94), Pol (N=86), and Nef (N=104 279 associations) ( Fig. 1 and Table S1 ). HLA-APs were more frequently detected in Nef 280 We next wished to investigate the relationship between the presence of HLA-associated 292 substitutions in each gene and patient HIV-1 plasma viral load (pVL) and CD4+ T cell 293 count (CD4 count) in the Japanese cohort. As described in the methods, substitutions within 294 a given HIV-1 sequence were counted as "HLA-associated" if they had been identified as 295 being associated with any HLA class I allele in our study, regardless of the HLA alleles 296 expressed by the patient. For example, Gag-9S is a HLA-B*15:01-associated nonadapted 297 polymorphism ( Fig. 1 and Table S1 ); as such, any amino acid other than "S" at codon 9 298 was counted as an HLA-associated substitution. Similarly, Gag-123G is an 299 HLA-C*01:02-associated adapted polymorphism (but no specific nonadapted forms, 300 restricted by C*01:02 or others, were identified at this position); as such, any sequence 301 harboring "G" at codon 123 was counted as having an HLA-associated substitution at this 302
site. 303
A weak yet statistically significant inverse correlation was observed between pVL and 304 the total number of HLA-associated substitutions in Pol (Spearman's R = −0.11; p = 0.04) 305 ( Fig. 2A) . However, no such correlations were observed for Gag (Spearman's R= −0.056, p 306 = 0.3) or Nef (Spearman's R= −0.029, p = 0.6) ( Fig. 2A) . Moreover, no significant 307 correlations were observed between the total number of HLA-associated substitutions in 308 any HIV protein, and CD4 count ( Fig. 2A) . Though the overall association is weak, results 309 raise the intriguing hypothesis that selection of certain HLA-driven substitutions in Pol 310 could modulate VL in the Japanese population. haplotype are examples of such protective alleles (24). As such, we investigated whether 315 they could play a role in the observed pVL correlation. No HLA-B*67:01-associated 316 substitution was identified in Pol, whereas four HLA-B*52:01-associated and one 317 HLA-C*12:02-associated substitutions were detected in this protein (Table S1 ). Exclusion 318 of the single HLA-C*12:02-associated substitution from analysis did not affect the 319 relationship between the number of HLA-associated substitutions in Pol and pVL (data not 320 shown). In contrast, exclusion of the four HLA-B*52:01-associated Pol substitutions 321 substantially weakened the overall relationship between the number of HLA-associated Pol 322 substitutions and pVL (Spearman's R = −0.057; p = 0.3) (Fig. 2B) . Similarly, specific 323 consideration of only HLA-B*52:01-associated Pol substitutions revealed a highly 324 significant inverse correlation with pVL (Spearman's R = −0.18; p = 0.0007) (Fig. 2C) that 325 represented the strongest such relationship detected in Pol for common HLA alleles 326 observed in our cohort (Fig. S2) . We therefore reasoned that B*52:01-restricted 327 substitutions were likely to be critical mediators of the observed pVL effect. 328 differential escape between closely-related HLA subtypes. In particular, we hypothesized 341 that HLA subtype members differing with respect to amino acids located within in the 342 peptide-binding groove of the HLA molecule may differ with respect to the nature (or 343 binding affinity) of the specific HIV epitopes presented (25-28), and therefore that they 344 may exhibit differential escape pathways. In contrast, HLA subtype members that differ 345 with respect to amino acids located outside the peptide-binding groove may be more likely 346 to present the same epitopes (29-31), and therefore will generally exhibit less evidence for 347 differential escape between them. Of the 284 HLA-AP identified in our cohort, 128 were 348 restricted by HLA allele groups (A*02, A*26, B*15, B*40, C*03, C*08, and C*14) 349 containing two or more subtype members (Table S1 ). For five of these allele groups (A*02, 350 A*26, B*15, B*40, and C*08), subtype members differed by substitutions within the 351 peptide-binding groove (Fig. S3) , supporting them as potential candidates for differential 352 HLA-AP selection. In contrast, members of the C*03 and C*14 subtypes differed by 353 substitutions outside the peptide-binding groove (Fig. S3) , suggesting that their epitope 354 repertoire (and thus escape pathways) would be more similar to one another. 355
We began by simply comparing HLA-AP identified in context of the different HLA 356 subtypes. As expected, viral polymorphisms associated with HLA subtype members 357 differing within their peptide-binding grooves appeared to be quite specific to each HLA 358 subtype (Fig. S3A, S3B, S3C, S3D, and S3F) . Surprisingly however, viral polymorphisms 359 associated with HLA subtype members differing only with respect to amino acids located 360 outside their peptide-binding grooves also appeared to be quite specific to each HLA 361 subtype ( Fig. S3E and S3G ). For example, HLA-C*03:03 and C*03:04, which differ only 362 by substitutions at position 91 that have no contact with the groove (29-31), were 363 associated with a total of 11 HLA-APs, none of which appeared to be shared (Fig. S2E) . 364
Similarly, HLA-C*14:02 and C*14:03, that differ only by a substitution at position 21 365 located outside of the floor of the peptide-binding groove (Fig. S2G) (Fig. S3B) . A total of 10 HLA-APs, located at 8 HIV codons, were 379 originally identified as associated with either HLA-A*26:01 or A*26:03 (Fig. S3B) . 380
Although qualitatively, all 10 HLA-APs appear to be differentially selected by 381 HLA-A*26:01 or A*26:03 (Fig. S3B) , the phylogenetically-corrected interaction test 382 revealed only 3 of them (located at Pol residues 276 and 551, and Nef residue 85) to be 383 significantly differentially selected in terms of their natural logarithm of the odds ratios of 384 association (p < 0.05, q < 0.2) (Fig. 3A) . Surprisingly, significant differential escape was 385 also observed between subtype members that differed only with respect to substitutions 386 outside of their peptide-binding grooves: 3 of 9 (33.3%) sites restricted by HLA-C*03 387 allele group members and 5 of 14 (35.7%) sites restricted by C*14 allele group members 388 similarly exhibited statistically significant evidence of differential selection (Fig. 3B and  389 
3C). 390
To compare whether the extent of differential escape between HLA subtype members 391 varied between HLA allele groups that differed with respect to substitutions within or 392 outside the binding groove, we asked whether the extent of differential escape between 393 on October 28, 2017 by guest http://jvi.asm.org/ Downloaded from subtype members of the former group (comprising A*02, A*26, B*15, B*40, and C*08) 394 differed compared to the latter group (comprising HLA-C*03 and C*14). Overall, we found 395 no significant differences in the proportion of differential escape between them (34.8% for 396 HLA-C*03/C*14 subtypes compared to 36.8% for subtypes of all other HLA alleles, p = 397 0.5) ( Table S2 ). This intriguing result suggests that variations outside the HLA binding 398 HLA-AP will differ to some extent between human populations due to the presence (or 409 enrichment) of certain HLA alleles in one population versus another. Indeed, HLA allele 410 frequencies differed markedly between the Japan and IHAC cohorts (Fig. S1 ). As such, we 411 begin with a qualitative comparison of HLA-AP between them. We begin with a simple 412 positional analysis. In the Japanese cohort, HLA-APs were observed at a total of 147 codon 413 positions in Gag, Pol, and Nef (Fig. 4) . Of these, 117 (79.6%) were also associated with at 414 least one HLA allele in IHAC. In contrast, the remaining 30 positions (including 16, 7 and 415 7 in Gag, Pol, and Nef, respectively) that harbored HLA associations in Japan were not 416 associated with any HLA alleles in IHAC (Fig. 4) . ; Table S3) confirm that the strength of selection of Nef-125H by B*44:03 is 461 significantly greater in Japan compared to IHAC. Importantly, this difference is not simply 462 attributable to intercohort differences in B*44:03 frequency (which is comparable between 463 populations; Fig S1) . 464
In addition to the HLA-B*44:03-associated 125H polymorphism in Nef, we identified 465 21 other HLA-AP whose strengths of selection were significantly greater in Japan 466 compared to IHAC, yielding a total of 22 (of 71; 31.0%) HLA-APs in this category. 467
Conversely, 39 (of 71; 54.9%) differentially-selected HLA-AP exhibited strengths of 468 selection that were greater in IHAC compared to Japan. The HLA-A*26:01-associated 469 889S substitution in Pol serves as an example. The lnOR of this association is −0.18 in 470 Japan (with a cohort-specific p-value of 0.3) versus −1.17 for IHAC (with a cohort-specific 471 p-value of 7.92 × 10 −9 ). Both lnORs are negative, indicating that 889S is negatively 472 associated with A*26:01 in both cohorts, but the more negative value for IHAC indicates 473 that this association is stronger in IHAC compared to Japan. Table S3 ) 487 confirm that the opposing direction of selection of Nef-120F by B*44:03 between Japanese 488 and IHAC cohorts is a statistically significant observation. 489
Of interest, the 71 HLA-APs identified as being under significantly different selection 490 between Japan and IHAC cohorts were differentially distributed across HLA loci and HIV 491 proteins ( Fig. 6A and 6B) . Specifically, HLA-A-associated polymorphisms that were 492 significantly differentially selected across cohorts were most abundant in Gag, followed by 493
Pol and Nef, whereas differentially-selected HLA-B-associated and HLA-C-associated 494 polymorphisms were most numerous in Nef, followed by Pol and Gag. Taken and Nef in our cohort, supporting a strong influence of population-specific, HLA-driven 519 immune pressures in shaping HIV-1 evolution in Japan. In contrast to a previous study 520 undertaken in a predominantly Caucasian population that observed approximately one-half 521 of the total number of Gag HLA-APs to be located within or flanking reported CTL 522 epitopes (3), the majority of HLA-APs identified in the present study were not located 523 nearby reported CTL epitopes. This discrepancy may be due to the limited number of 524
Asian-specific HLA-restricted CTL epitopes identified to date, underscoring the need for 525 further epitope discovery in these populations. Protective HLA alleles such as HLA-B*57, B*58, and B*27, select Gag mutations 542 affecting viral replication in Caucasians and Africans (36-41) that may also provide some 543 clinical benefit if they are transmitted to hosts lacking these alleles (42, 43). HLA-B*57, 544 B*58, and B*27 are not present at appreciable frequencies in Japan (23). It is therefore 545 perhaps unsurprising that no correlations between HLA-associated substitutions in Gag and 546 HIV clinical parameters were observed in our cohort. In contrast, we observed a weak but 547 significant inverse correlation between the frequency of HLA-APs in Pol and plasma viral 548 load, which appeared to be driven by polymorphisms selected by HLA-B*52:01, an allele 549 identified as protective in Japan (24). Upon further stratification by HLA-B*52:01 550 expression, the inverse correlation between VL and the total number of B*52:01-associated 551
Pol substitutions was maintained in HLA-B*52:01 − , but not in HLA-B*52:01 + individuals. 552
Taken together, these findings suggest that transmitted B*52:01-associated polymorphisms 553 could reduce viral fitness in a dose-dependent manner, though further studies would be 554 required to assess this. In addition, these substitutions were not located within or nearby 555 on October 28, 2017 by guest http://jvi.asm.org/ Downloaded from 23 known B*52:01-restricted epitopes. Thus, further research would be required to identify 556 these epitopes and elucidate their mechanisms of escape. 557
Many previous studies of HLA-APs were performed at 2-digit HLA resolution (1-4, 6) . 558
Here, we performed HLA genotyping at 4-digit resolution, which allowed us to investigate 559 differential escape between closely-related HLA subtypes in the Japanese cohort. Nearly 560 one half of the HLA-AP identified in Japan were restricted by HLA allele groups 561 containing two or more subtype members (A*02, A*26, B*15, B*40, C*03, C*08, and 562 C*14). For five of these groups (A*02, A*26, B*15, B*40, and C*08), subtype members 563 differed by substitutions within the peptide-binding groove, while for the remaining two 564 groups (HLA-C*03 and -C*14), subtype members differed by substitutions located outside 565 the peptide binding groove. Reasoning that amino acid differences located within the 566 peptide-binding groove could modulate the nature or presentation of CTL epitopes, we 567 hypothesized that the former group would generally exhibit distinct HLA-AP between 568 subtype members, while the latter would generally exhibit similar or identical HLA-AP. 569
However, we were surprised to observe substantial evidence for differential HLA-AP 570 selection between closely-related HLA subtypes regardless of whether they differed in 571 sequence within or outside the peptide binding groove. Significantly differential HLA-AP 572 selection was observed at 3 of 9 HLA-C*03 associated sites and 5 of 14 HLA-C*14 573 associated sites (Fig. 3) , proportions that were not significantly lower than the frequency of 574 differential selection between subtypes that differed in their peptide-binding groove. 
